Drug Regulator of India seeks data from Dr. Reddy’s Lab on Sputnik V
sputnik vaccine in India
An expert panel of India’s drug regulator on Friday sought additional data from drugmaker Dr. Reddy’s Laboratories on its Sputnik V Covid-19 vaccine trial, in its second such request after an initial evaluation in February.
Dr. Reddy’s has been conducting small clinical trials with Sputnik V in India under a deal with Russia’s wealth fund. Several Indian companies have signed deals to produce and supply over a half a billion doses of the vaccine.
The Committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study, as well as data on serious adverse events and positive cases reported till date.
Source: Reuters
Recent Posts
Mounjaro Launched in India: Price & Impact on Diabetes and Obesity
Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…
Shocking Rabies Case in Greater Noida Challenges Common Misconceptions
A recent case of rabies transmission in Greater Noida has sent shockwaves through the community,…
Punjab Government to Ban Energy Drinks in Schools and Colleges for Student Health
The Punjab government is set to ban high-caffeine energy drinks in schools, citing severe health…
Experts Warn of Global Threat from Chronic Wasting Disease
Chronic Wasting Disease (CWD) is a highly contagious and fatal neurological disorder that affects deer,…
CDC Reschedules Vaccine Advisory Meeting to April 15-16
The Centers for Disease Control and Prevention (CDC) has announced a rescheduling of its vaccine…
India’s Specialty Chemicals Rebound, Pharma Exports Surge
India’s specialty chemicals industry and pharmaceutical exports continue to showcase resilience amid global uncertainties. As…